Literature DB >> 9036861

Expression of high-mobility group-1 mRNA in human gastrointestinal adenocarcinoma and corresponding non-cancerous mucosa.

Y Y Xiang1, D Y Wang, M Tanaka, M Suzuki, E Kiyokawa, H Igarashi, Y Naito, Q Shen, H Sugimura.   

Abstract

An 1194-nucleotide complementary DNA clone, FM1, encoding a human high-mobility group-1 protein (HMG-1) was isolated from a well-differentiated human gastric-carcinoma cell line complementary DNA library by a differential screening method. FM1 is similar to the published human HMG-1 in mature protein, with only 3 different codons at positions 11, 149, and 190. We analyzed 33 gastric and colorectal adenocarcinomas for expression of the FM1 gene. Northern-blot analysis revealed that all of the cancers expressed FM1 at a higher level than in corresponding non-cancerous mucosa, with 2 transcripts of approximately 1.4 and 2.4 kilobases. The FM1 expression level in the non-cancerous tissues increased with the depth of accompanying cancer invasion. Only 18.2% of well-differentiated cancers showed a higher expression level in corresponding non-cancerous tissues, whereas the expression in corresponding non-cancerous tissues was significantly higher in moderately (60%) and poorly differentiated (83.3%) cancers. In situ hybridization demonstrated the location of FM1 mRNA in well- and poorly differentiated gastric-cancer cells as well as in non-cancerous tissue adjacent to poorly differentiated gastric cancer, but no hybridization was detected in normal epithelial cells adjacent to well-differentiated gastric cancer. These findings may provide new information on HMG-1 mRNA expression in human gastrointestinal cancer and suggest a correlation between FM1 mRNA expression to the differentiation and the stage of human gastrointestinal adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9036861     DOI: 10.1002/(sici)1097-0215(19970220)74:1<1::aid-ijc1>3.0.co;2-6

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas.

Authors:  K Völp; M-L Brezniceanu; S Bösser; T Brabletz; T Kirchner; D Göttel; S Joos; M Zörnig
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

Review 2.  High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.

Authors:  S S Liau; E Whang
Journal:  Surgeon       Date:  2009-10       Impact factor: 2.392

Review 3.  HMGB1 in hormone-related cancer: a potential therapeutic target.

Authors:  Madhuwanti Srinivasan; Souresh Banerjee; Allison Palmer; Guoxing Zheng; Aoshuang Chen; Maarten C Bosland; André Kajdacsy-Balla; Ramaswamy Kalyanasundaram; Gnanasekar Munirathinam
Journal:  Horm Cancer       Date:  2014-04-10       Impact factor: 3.869

4.  Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype.

Authors:  Ina Poser; Michaela Golob; Reinhard Buettner; Anja K Bosserhoff
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

5.  The expression of HMGB1 protein and its receptor RAGE in human malignant tumors.

Authors:  Nora Kostova; Stanislava Zlateva; Iva Ugrinova; Evdokia Pasheva
Journal:  Mol Cell Biochem       Date:  2009-10-30       Impact factor: 3.396

Review 6.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

7.  HMGA1 is induced by Wnt/beta-catenin pathway and maintains cell proliferation in gastric cancer.

Authors:  Shin-ichi Akaboshi; Sugiko Watanabe; Yuko Hino; Yoko Sekita; Yang Xi; Kimi Araki; Ken-ichi Yamamura; Masanobu Oshima; Takaaki Ito; Hideo Baba; Mitsuyoshi Nakao
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

8.  Amino acid function and docking site prediction through combining disease variants, structure alignments, sequence alignments, and molecular dynamics: a study of the HMG domain.

Authors:  Jeremy W Prokop; Thomas C Leeper; Zhong-Hui Duan; Amy Milsted
Journal:  BMC Bioinformatics       Date:  2012-03-13       Impact factor: 3.169

9.  Proteomic alteration in gastic adenocarcinomas from Japanese patients.

Authors:  Takahiro Yoshihara; Yoshito Kadota; Yoshiyuki Yoshimura; Yutaka Tatano; Naohiro Takeuchi; Hiroshi Okitsu; Atsushi Umemoto; Takashi Yamauchi; Kohji Itoh
Journal:  Mol Cancer       Date:  2006-12-25       Impact factor: 27.401

10.  Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer.

Authors:  Hye Won Chung; Sang-Guk Lee; Heejung Kim; Duck Jin Hong; Jae Bock Chung; David Stroncek; Jong-Baeck Lim
Journal:  J Transl Med       Date:  2009-05-28       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.